NOVONIX Ltd Files Form 6-K

Ticker: NVNXF · Form: 6-K · Filed: Dec 12, 2024 · CIK: 1859795

Sentiment: neutral

Topics: disclosure, foreign-private-issuer, sec-filing

TL;DR

NOVONIX files routine 6-K, confirms 20-F reporting for 2024.

AI Summary

NOVONIX Ltd filed a Form 6-K on December 12, 2024, reporting information as of December 12, 2024. The filing is for the month of December 2024 and indicates that NOVONIX Limited is a foreign private issuer submitting its annual reports under Form 20-F. The company is incorporated in Australia and its principal executive office is located in Brisbane.

Why It Matters

This filing provides routine updates and disclosures for NOVONIX Ltd as a foreign private issuer, which is important for investors tracking the company's compliance and reporting status.

Risk Assessment

Risk Level: low — This is a standard Form 6-K filing, which typically contains routine disclosures and does not indicate significant new risks.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of December 2024.

Does NOVONIX Ltd file its annual reports under Form 20-F or Form 40-F?

NOVONIX Ltd indicates it files its annual reports under cover of Form 20-F.

Where is NOVONIX Ltd's principal executive office located?

NOVONIX Ltd's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.

What is the SEC file number for NOVONIX Ltd?

The SEC file number for NOVONIX Ltd is 001-41208.

What is the SIC code for NOVONIX Ltd?

The Standard Industrial Classification (SIC) code for NOVONIX Ltd is 3690 (MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES).

Filing Stats: 196 words · 1 min read · ~1 pages · Grade level 13.1 · Accepted 2024-12-12 16:30:02

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: December 12, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing